default author photo

Suprateek Kundu

University of Texas at Houston - MD Anderson Cancer Center

Unit 1905

Houston, TX

United States

  • University of Texas at Houston - MD Anderson Cancer Center

SCHOLARLY PAPERS

2

DOWNLOADS

106

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Safety and Efficacy of a New High-Dose Chemotherapy Regimen of Panobinostat, Gemcitabine, Busulfan and Melphalan for 1st or 2nd Salvage Autologous Stem Cell Transplant for Patients with Refractory/Relapsed or High-Risk Myeloma: Matched Pair Comparisons with Concurrent Control Cohorts

Number of pages: 33 Posted: 10 Aug 2023
Yago Nieto, Zixi Yang, Benigno C. Valdez, Roland Bassett, Suprateek Kundu, Melissa Barnett, Qaiser Bashir, Jeremy Ramdial, Jin Im, Partow Kebriaei, Uday Popat, Neeraj Y. Saini, Samer Srour, Jitesh Kawedia, Alison Gulbis, Rita Cool, Vi Doan, Terri Lynn Shigle, Whitney Wallis, Ruby Delgado, Sofia Qureshi, Hans C. Lee, Elisabet E. Manasanch, Robert Z. Orlowski, Krina K. Patel, Elizabeth J. Shpall, Borje S. Andersson and Muzaffar Qazilbash
University of Texas at Houston - Department of Biostatistics, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center and University of Texas at Houston - MD Anderson Cancer Center
Downloads 72 (860,052)

Abstract:

Loading...

Myeloma, autologous stem-cell transplant, high-dose chemotherapy, phase 2 trial, matched pair comparison

2.

Rewiring BCL6 with Transcriptional/epigenetic Chemical Inducers of Proximity Unveils Targetable Plasticity in Large B Cell Lymphoma

Number of pages: 61 Posted: 16 Jun 2026
Haopeng Yang, Kevin Bowman, Wenzhi Ji, Sai Gourisankar, Zihan Yang, Brendan Dwyer, Yanlan Wang, Tania Sainz, Bijal Thakkar, Ashley Wilson, Ethan Marszalek, Stephen Hinshaw, Tinghu Zhang, Xiaofan Liu, Bryan Romero, Ines Forrest, Juste Simanauskaite, Roman Sarrot, Basel Karim, Andrey Krokhotin, Sabin Nettles, Christopher R. Flowers, James R. Cerhan, Jean L. Koff, Sanjay Patel, Francisco Vega, Xubin Li, Suprateek Kundu, Gerald R. Crabtree, Nathanael Gray, Michael Green and Sneak Peek Administrator
University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, Stanford University, Stanford University, University of Texas at Houston - Department of Lymphoma and Myeloma, Stanford University, Stanford University, University of Texas at Houston - Graduate School of Biological Sciences, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, Stanford University, Stanford University, Stanford University, Stanford University, Stanford University, Stanford University, Stanford University, Stanford University, Stanford University, Stanford University, University of Texas at Houston - Department of Lymphoma and Myeloma, Mayo Clinic, Emory University, Cornell University - Pathology and Laboratory Medicine, UT MD Anderson Cancer Center, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - MD Anderson Cancer Center, Stanford University - Howard Hughes Medical Institute, Stanford University - Department of Chemical and Systems Biology, University of Texas at Houston - Department of Lymphoma and Myeloma and Independent
Downloads 34

Abstract:

Loading...

Lymphoma, BCL6, epigenetics, plasticity